TP53 and small cell lung carcinoma: Dual inactivation of the TP53 and RB1 genes has been found in > 80% of all ‘pure’ SCLC tumors [2, 25] and has been proven to play a key role in genetically engineered mouse models (GEMMs) of this disease.